Clinical Trials Browser

Observational × Adenocarcinoma × 90 days × Clear all

NCT00923026 2026-04-20

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

Enrolling by invitation

DermatologicEndocrineNET

Adenocarcinoma, Carcinoma, Melanoma, Neuroendocrine Tumors

NCT07484971 2026-04-17

CLIQQC

Adenocarcinoma, Disease, Neoplasms, Prostatic Neoplasms

NCT07516886 2026-04-08

PPSARP

Adenocarcinoma, Disease, Prostatic Neoplasms

NCT06504615 2026-04-03

METAGIO

Active not recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Adenocarcinoma

NCT07124000 2026-03-31

DP-04

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Adenocarcinoma, Anus Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Melanoma, Mouth Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gastrointestinal Stromal Tumors, Small Cell Lung Carcinoma

NCT06128343 2026-03-19

BACAP-2

Adenocarcinoma, Carcinoma, Neoplasms

NCT06902545 2026-03-11

A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

Adenocarcinoma, Neoplasms

NCT07460726 2026-03-10

PRIAPUS-PCa

Not yet recruiting

Adenocarcinoma, Erectile Dysfunction, Prostatic Neoplasms

NCT06996249 2026-03-03

DuTOC

12,000 enrolled

Other solid neoplasmThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Mesothelioma, Thymus Neoplasms

NCT07439913 2026-02-27

Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer

Enrolling by invitation

Adenocarcinoma, Prostatic Neoplasms

NCT07407608 2026-02-12

ABRUPT 2

Adenocarcinoma, Prostatic Neoplasms

NCT00349830 2026-02-10

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

Adenocarcinoma, Carcinoma, Neoplasms

NCT06834152 2026-02-09

X-SMILE

Adenocarcinoma, Prostatic Hyperplasia, Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT07370597 2026-01-27

LUDOPATH

Adenocarcinoma, Prostatic Neoplasms